These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23157919)

  • 1. Clinical and therapeutic evaluation of patients with moderate to severe psoriasis in Spain: the secuence study.
    Hernánz JM; Sánchez-Regaña M; Izu R; Mendiola V; García-Calvo C
    Actas Dermosifiliogr; 2012 Dec; 103(10):897-904. PubMed ID: 23157919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Therapeutic Evaluation of Patients with Moderate to Severe Psoriasis in Spain: The Secuence Study.
    Hernánz JM; Sánchez-Regaña M; Izu R; Mendiola V; García-Calvo C
    Actas Dermosifiliogr; 2012 Dec; 103(10):897-904. PubMed ID: 22748300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What characterizes the severity of psoriasis? Results from an epidemiological study of over 3,300 patients in the Iberian region.
    García-Diez A; Foraster CF; Sebastián FV; Tudela LL; Llach XB; Fernández GS
    Dermatology; 2008; 216(2):137-51. PubMed ID: 18216476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of the cost effectiveness of home-based phototherapy with narrow-band UV-B radiation compared with biological drugs for the treatment of moderate to severe psoriasis].
    Vañó-Galván S; Gárate MT; Fleta-Asín B; Hidalgo A; Fernández-Guarino M; Bermejo T; Jaén P
    Actas Dermosifiliogr; 2012 Mar; 103(2):127-37. PubMed ID: 22036021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy of biologics versus conventional systemic therapies in the treatment of psoriasis at a comprehensive psoriasis care center.
    Au SC; Madani A; Alhaddad M; Alkofide M; Gottlieb AB
    J Drugs Dermatol; 2013 Aug; 12(8):861-6. PubMed ID: 23986158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TUR-PSO: A cross-sectional, study investigating quality of life and treatment status of psoriasis patients in Turkey.
    Atakan N; Yazici AC; Özarmağan G; İnalÖz HS; Gürer MA; Sabuncu İ; Kİremİtçİ Ü; Alper S; Aytekİn S; Arican Ö; Polat M; Doğan S; Aldİnç E
    J Dermatol; 2016 Mar; 43(3):298-304. PubMed ID: 26365805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Opinion of Spanish dermatologists regarding the use of biologic therapy in patients with moderate to severe psoriasis].
    Ara M; Pérez A; Ferrando J
    Actas Dermosifiliogr; 2011 Nov; 102(9):706-16. PubMed ID: 21600532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriasis treatment patterns: results of a cross-sectional survey of dermatologists.
    Patel V; Horn EJ; Lobosco SJ; Fox KM; Stevens SR; Lebwohl M
    J Am Acad Dermatol; 2008 Jun; 58(6):964-9. PubMed ID: 18378352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life and related factors in a cohort of plaque-type psoriasis patients in La Coruña, Spain.
    Fernández-Torres RM; Pita-Fernández S; Fonseca E
    Int J Dermatol; 2014 Nov; 53(11):e507-11. PubMed ID: 25266080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of adalimumab in the treatment of psoriasis: a retrospective study of 15 patients in daily practice.
    Sola-Ortigosa J; Sánchez-Regaña M; Umbert-Millet P
    J Dermatolog Treat; 2012 Jun; 23(3):203-7. PubMed ID: 21787203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clobetasol propionate spray 0.05% add-on therapy to a stable regimen of biologic treatment in patients with moderate to very severe plaque psoriasis.
    Feldman SR; Koo JY; Johnson LA; Preston NJ
    Cutis; 2009 Oct; 84(4 Suppl):25-32. PubMed ID: 19916299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic Treatment of Moderate to Severe Psoriasis in Pediatric Patients in Galicia, Spain: A Descriptive Study.
    Batalla A; Fernández-Torres R; Rodríguez-Pazos L; Monteagudo B; Pardavila-Riveiro R; Rodríguez-Lojo R; Zulaica Á; Cabanillas M; Fonseca E; León Á; Fernández-Díaz L; Abalde T; Salgado-Boquete L; Valdés F; Seoane-Pose MJ; Vázquez-Veiga H; Suárez-Conde I; Álvarez-López J; Flórez Á
    Actas Dermosifiliogr (Engl Ed); 2018 Oct; 109(8):722-732. PubMed ID: 30293554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant delay in the introduction of systemic treatment of moderate to severe psoriasis: a prospective multicentre observational study in outpatients from hospital dermatology departments in France.
    Maza A; Richard MA; Aubin F; Ortonne JP; Prey S; Bachelez H; Beylot-Barry M; Bulai-Livideanu C; Lahfa M; Nougué J; Mengual X; Le Moigne M; Lauwers-Cances V; Paul C
    Br J Dermatol; 2012 Sep; 167(3):643-8. PubMed ID: 22512545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of clinical use of etanercept for the treatment of moderate-to-severe psoriasis in Spain: results of a multicentric prospective study at 12 months follow-up.
    Puig L; Camacho Martínez FM; Gimeno Carpio E; López-Ávila A; García-Calvo C
    Dermatology; 2012; 225(3):220-30. PubMed ID: 23235195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label, prospective cohort pilot study to evaluate the efficacy and safety of etanercept in the treatment of moderate to severe plaque psoriasis in patients who have not had an adequate response to adalimumab.
    Vender R
    J Drugs Dermatol; 2011 Apr; 10(4):396-402. PubMed ID: 21455550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survey of disease severity, quality of life, and treatment patterns of biologically naive patients with psoriasis in central and eastern Europe.
    Palota T; Szepietowski JC; Pec J; Arenberger P; Giurcaneanu C; Gyulai R; Miljkovic J; Pärna E; Mikazans I; Grusauskas N; Hodik M
    Acta Dermatovenerol Croat; 2010; 18(3):151-61. PubMed ID: 20887696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PSOLAR: design, utility, and preliminary results of a prospective, international, disease-based registry of patients with psoriasis who are receiving, or are candidates for, conventional systemic treatments or biologic agents.
    Papp KA; Strober B; Augustin M; Calabro S; Londhe A; Chevrier M;
    J Drugs Dermatol; 2012 Oct; 11(10):1210-7. PubMed ID: 23134986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of psoriasis.
    Al-Kudwah AJ; Feldman SR
    South Med J; 2009 Jun; 102(6):631-6. PubMed ID: 19434023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moderate to severe psoriasis: from topical to biological treatment.
    Gardinal I; Ammoury A; Paul C
    J Eur Acad Dermatol Venereol; 2009 Nov; 23(11):1324-6. PubMed ID: 19470061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs and quality of life in patients with moderate to severe plaque-type psoriasis in Germany: a multi-center study.
    Schöffski O; Augustin M; Prinz J; Rauner K; Schubert E; Sohn S; Reich K
    J Dtsch Dermatol Ges; 2007 Mar; 5(3):209-18. PubMed ID: 17338796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.